Source study found
Story checked
Can maternal diet prevent infant food allergy? A large trial puts eggs and peanuts to the test (opens in a new tab)
news-medical.net · 2026-09-17
Short answer
MixedMixed.
One claim goes further than the study. 2 other points were not covered by the paper.
- 3 supported
- 1 overstated
- 2 not covered
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Can maternal diet prevent infant food allergy? A large trial puts eggs and peanuts to the test
news-medical.net · 2026-09-17
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Mixed
One claim overstates the study. Three of six check out. Two claims the study doesn't address.
- 3 supported
- 1 overstated
- 2 not covered
The source study
Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy
Evidence layer
Claim by claim
Each claim gets a verdict. Expand it to see the evidence directly below.
Reading mode
Scan verdicts. Open evidence only when needed.
Browse by verdict
6 claims in this storyShowing all 6 claimsChoose a verdict to focus the list.
Claim 1 of 6OverstatedThe authors concluded that higher maternal intake of eggs and peanuts during pregnancy and lactation did not reduce or increase the risk of IgE-mediated egg or peanut allergy in infants, and they pointed to separate evidence supporting timely introduction of egg and peanut directly into the infant diet.View evidenceHide evidence
Why this verdict
The profile supports the conclusion that high maternal egg/peanut intake did not significantly lower infant allergy risk at 1 year. But the story’s wording that it 'did not reduce or increase' risk is stronger than the abstract evidence: the confidence interval includes possible benefit and possible harm, and the profile does not establish equivalence or absence of any increase. The additional point about separate evidence supporting timely direct infant introduction is not verifiable from the supplied abstract profile.
Study evidence
No significant difference in the proportion of infants with IgE-mediated egg or peanut allergy at 1 year between maternal high egg-peanut diet and standard diet.Relative risk 0.93 (95% CI 0.69 to 1.26), P = 0.65
“In this multisite, randomized trial… Participants were assigned in a 1:1 ratio to follow either a diet high in eggs and peanuts… or a standard (control) egg and peanut diet…”
Claim 2 of 6Not coveredThe PrEggNut trial enrolled 2,137 pregnant women in Australia and randomized them to a high egg-peanut diet or a standard diet; the high-intake diet called for at least 6 eggs and 60 peanuts per week from enrollment until 4 months after delivery or until breastfeeding ended.View evidenceHide evidence
As stated2,137 women; at least 6 eggs and 60 peanuts per week
Why this verdict
Most design details are supported by the abstract profile: 1070 and 1067 randomized participants, high diet target of at least 6 eggs and 60 peanuts per week, standard diet comparator, and intervention from before 23 weeks’ gestation through 4 months postpartum. However, the abstract profile does not verify the Australia location or the exact stopping condition phrased as 'or until breastfeeding ended.'
Study evidence
No significant difference in the proportion of infants with IgE-mediated egg or peanut allergy at 1 year between maternal high egg-peanut diet and standard diet.Relative risk 0.93 (95% CI 0.69 to 1.26), P = 0.65
“In this multisite, randomized trial… Participants were assigned in a 1:1 ratio to follow either a diet high in eggs and peanuts… or a standard (control) egg and peanut diet…”
Claim 3 of 6Not coveredThe article says the null result remained unchanged in analyses restricted to women who breastfed for 4 months with adequate adherence, and no apparent differences were found in safety outcomes.View evidenceHide evidence
As stated5.6% versus 6.8% in the adherent subgroup; serious adverse events 3.6% versus 3.8%
Why this verdict
The abstract profile supports only the broad statement that safety measures were similar between groups. It does not provide the claimed adherent/breastfed-for-4-month subgroup analysis, the 5.6% versus 6.8% figures, or the serious-adverse-event rates of 3.6% versus 3.8%. Those details require full-text or supplementary evidence beyond the supplied abstract profile.
Study evidence
No significant difference in the proportion of infants with IgE-mediated egg or peanut allergy at 1 year between maternal high egg-peanut diet and standard diet.Relative risk 0.93 (95% CI 0.69 to 1.26), P = 0.65
“In this multisite, randomized trial… Participants were assigned in a 1:1 ratio to follow either a diet high in eggs and peanuts… or a standard (control) egg and peanut diet…”
Study evidence
The abstract reports that safety measures were similar in the high egg–peanut and standard-diet groups.
“Safety measures were similar in the two groups.”
Claim 4 of 6SupportedA large randomized trial published in the New England Journal of Medicine found that increasing maternal consumption of eggs and peanuts during pregnancy and breastfeeding did not significantly reduce the risk of egg or peanut allergy in infants at 1 year of age who had a strong family history of allergic disease.View evidenceHide evidence
As statedno significant reduction
Why this verdict
The profile describes a multisite randomized trial of pregnant women whose unborn child had at least two biologic family members with medically diagnosed allergic disease, comparing high versus standard maternal egg/peanut intake. The primary outcome showed no statistically significant reduction in infant IgE-mediated egg or peanut allergy at 1 year: RR 0.93, 95% CI 0.69 to 1.26, P=0.65. The profile does not independently verify journal placement, but the scientific claim is supported.
Study evidence
No significant difference in the proportion of infants with IgE-mediated egg or peanut allergy at 1 year between maternal high egg-peanut diet and standard diet.Relative risk 0.93 (95% CI 0.69 to 1.26), P = 0.65
“In this multisite, randomized trial… Participants were assigned in a 1:1 ratio to follow either a diet high in eggs and peanuts… or a standard (control) egg and peanut diet…”
Claim 5 of 6SupportedAustralian researchers tested whether greater exposure to egg and peanut before birth and during breastfeeding could help shape food tolerance before infants begin eating these allergens themselves.View evidenceHide evidence
Why this verdict
The abstract-level profile supports that the trial tested a maternal high egg-and-peanut diet during pregnancy and lactation as a prevention strategy for infant IgE-mediated egg or peanut allergy. The mechanistic wording about shaping tolerance is speculative and consistent with the stated rationale that early immune responses and prenatal/lactational exposure were being investigated.
Study evidence
No significant difference in the proportion of infants with IgE-mediated egg or peanut allergy at 1 year between maternal high egg-peanut diet and standard diet.Relative risk 0.93 (95% CI 0.69 to 1.26), P = 0.65
“In this multisite, randomized trial… Participants were assigned in a 1:1 ratio to follow either a diet high in eggs and peanuts… or a standard (control) egg and peanut diet…”
Claim 6 of 6SupportedIgE-mediated egg or peanut allergy occurred in 83 of 1,066 infants (7.8%) in the high egg-peanut group and 89 of 1,064 infants (8.4%) in the standard-diet group, with no statistically significant difference in combined risk.View evidenceHide evidence
As stated7.8% versus 8.4%
Why this verdict
The stated event counts and percentages match the profile: 83/1066 infants, 7.8%, in the high egg-peanut group versus 89/1064, 8.4%, in the standard-diet group. The profile also reports no significant difference in the combined primary outcome, RR 0.93, 95% CI 0.69 to 1.26, P=0.65.
Study evidence
No significant difference in the proportion of infants with IgE-mediated egg or peanut allergy at 1 year between maternal high egg-peanut diet and standard diet.Relative risk 0.93 (95% CI 0.69 to 1.26), P = 0.65
“In this multisite, randomized trial… Participants were assigned in a 1:1 ratio to follow either a diet high in eggs and peanuts… or a standard (control) egg and peanut diet…”
Context layer
What the story carried across
Nothing material from the study was dropped.
5 things the story did carry across
- Primary study question: whether prescribing high maternal egg and peanut intake during pregnancy and lactation reduces infant IgE-mediated egg or peanut allergy at 1 year compared with a standard diet.
- Randomized trial design with approximately 1:1 allocation to high egg-peanut versus standard egg/peanut diet.
- Study population restricted to pregnancies at increased familial risk of allergic disease, defined in the profile as an unborn child with at least two biologic family members with medically diagnosed allergic disease.
- Main efficacy finding: no statistically significant difference in IgE-mediated egg or peanut allergy at 1 year, with 7.8% versus 8.4% and RR 0.93, 95% CI 0.69 to 1.26, P=0.65.
- Safety finding: abstract reports that safety measures were similar between the high egg-peanut and standard-diet groups.
Study layer
Study at a glance
Scan the study first. Expand only the parts you want to inspect.
Pieces of work
2
Evidence read
study summary
Lead result
human in vivo
1Lead resulthuman in vivoTest whether a maternal diet high in eggs and peanuts during pregnancy and lactation reduces IgE-mediated egg or peanut allergy in infants at 1 year of age compared with a standard (lower) egg/peanut diet.Multisite parallel-group randomized controlled trialExpandCollapse
In plain English
Multisite randomized trial (PrEggNut) assessed whether prescribing a high maternal intake of eggs and peanuts from before 23 weeks' gestation through 4 months postpartum reduced the risk of IgE-mediated egg or peanut allergy in offspring at 1 year, compared with a standard (lower) egg/peanut diet. No significant difference in the primary outcome was observed.
Key findings
- No significant difference in the proportion of infants with IgE-mediated egg or peanut allergy at 1 year between maternal high egg-peanut diet and standard diet.Relative risk 0.93 (95% CI 0.69 to 1.26), P = 0.65
- Safety measures were similar between the high egg-peanut and standard-diet groups.
“In this multisite, randomized trial… Participants were assigned in a 1:1 ratio to follow either a diet high in eggs and peanuts… or a standard (control) egg and peanut diet…”
What this piece can’t prove
- Population restricted to pregnancies at increased familial risk of allergic disease (≥2 biologic family members with diagnosed allergic disease), which may affect generalizability.
1 further detail could not be confirmed from the summary.
2human in vivoAssess safety/tolerability of prescribing high maternal egg and peanut intake during pregnancy and lactation (maternal/infant safety measures).randomized trial harms comparisonExpandCollapse
In plain English
In this randomized multisite trial (PrEggNut), investigators compared maternal diets high versus standard in eggs and peanuts from before 23 weeks' gestation through 4 months postpartum and reported that safety measures were similar between groups.
Key findings
- The abstract reports that safety measures were similar in the high egg–peanut and standard-diet groups.
“Safety measures were similar in the two groups.”
What this piece can’t prove
2 further details could not be confirmed from the summary.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy
The New England journal of medicine · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
PubMed, Europe PMC, Crossref · 15 candidate papers
Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy
The New England Journal of Medicine · 2026 · PubMed, Europe PMC, Crossref
Review for "Creation of a standardized egg ladder for IgE-mediated egg allergy"
2025 · Crossref
Prenatal, Perinatal and Postnatal Exposures and Clinical Factors of Food Allergy Prevention: A Review for the First 1000 Days of Life from the SIAIP Primary and Secondary Prevention of Allergic Diseases Commission.
Nutrients · 2026 · PubMed, Europe PMC
Maternal and Infant Dietary Patterns Are Not Related to Food Allergy Risk in Singapore Children: GUSTO Cohort Study.
The Journal of Nutrition · 2024 · PubMed
Review for "Use of an Egg Ladder for home egg introduction in children with IgE mediated egg allergy"
2021 · Crossref
Diet during Pregnancy and Allergy Onset in the Childhood: A Systematic Literature Review and Meta-Analysis.
2026 · Europe PMC
And 9 more candidates considered.